Skip to content

Case Study: Amendment for Officer Exculpation. Shareholder Meeting Advisory, Institutional Investor Intelligence, Retail Outreach

NASDAQ Listed Small Cap Biotechnology Company

A medical specialist looking at a specimen

Assignment and Challenges

A small cap biotechnology company was facing a shareholder vote to amend its certificate of incorporation to allow for officer exculpation provisions. There were two significant obstacles to passing this vote:

  1. The vote requirement to pass the proposal was 2/3’s of the outstanding shares voting in favor. While this vote requirement is mathematically possible, from a practical standpoint this threshold is rarely achieved.
  2. Complicating matters, Glass Lewis recommended voting against these proposals, so negative votes were present at the start of the solicitation from institutions that follow Glass Lewis recommendations.

Solution

Knowing that this vote would be a challenge, Alliance Advisors brought three internal teams to the solicitation: Shareholder Meeting Advisory, Institutional Investor Intelligence and Retail Outreach.

At the onset, our Institutional Investor team began identifying all of the financial institutions, custodial relationships, and beneficial shareholders present on the Non-Objecting Beneficial Owners (NOBO) list. Using our proprietary data, Alliance Advisors was able to precisely identify the underlying investors behind each custodian.

Once the institutional investors were identified, our team began the outreach process to obtain voting instructions. Simultaneously, our Retail Outreach team began soliciting retail shareholders to facilitate telephone, text and email voting.

Both groups use a combination of our proprietary text-to-vote, email-to-vote and live telephone voting platforms. These technologies are designed to allow us to gather votes from both the institutional and retail shares, down to the smallest shareholder.

Results

Despite 7% of the outstanding shares voting against the proposal, Alliance Advisors was able to successfully deliver the required vote. A quorum of 84% of the outstanding shares was achieved with 67% of the outstanding shares voting in favor of the Officer Exculpation Amendment. By designing a campaign that focused on maximizing participation from both institutional and retail shareholders, Alliance Advisors was able to deliver an exceptionally high quorum to overcome the negative votes.

Shareholder Meeting Advisory & Retail Outreach, Institutional Investor Intelligence

NASDAQ Listed Small Cap Biotechnology Company

Alliance Advisors Logo Transparent

New York • Washington DC • Toronto • Vancouver
Londres • Durban • Taipei • Hong Kong • Séoul

New York

800 3e Avenue, 17e étage
New York
NY 10022

Get in touch

Siège social mondial

Le centre d’affaires Overlook
150 Clove Road, Suite 400
Little Falls, NJ 07424

Get in touch

Siège social Europe

Tour 42
25, rue Old Broad
Londres, EC2N 1HN

Get in touch

Siège social Asie-Pacifique

23e étage, One Chinachem Central,
22, chemin Des Voeux, Central,
Central, Hong Kong

Get in touch

Canada

400 – 22 E 5th Avenue
Vancouver, C.-B. V5T 1G8

Get in touch

Alliance Advisors est un cabinet de conseil indépendant spécialisé dans les services liés aux assemblées générales, à l’engagement des actionnaires, à la rémunération, à la gouvernance et au développement durable, grâce à notre réseau mondial.

Nous allons plus loin, de l’élaboration à la mise en œuvre de stratégies audacieuses axées sur le client, pour aboutir à des résultats gagnants.

Nos services

NOUS CONTACTER